and Bruce and Ramirez (1970) showed that direct implant of estradiol into the median eminence or pituitary did not inhibit lactation, but on the contrary, caused a stimulation of lactation in the rat. These results indicate that the inhibitory effect of estrogen upon lactation is not exerted at the pituitary level and also suggest that it is not attributed to the prolactin defficiency in its absolute amounts. There is considerable evidence that adrenal corticoids, in addition to prolactin, play an important role in maintenance of lactation as well as initiation of lactation (see Cowie, 1966) . Insofar as initiation of lactation is concerned, a relative antagonism is postulated to exist between the-effects of ovarian hormones on one hand and prolactin and adrenal cortical hormones on the other hand, and the changes in the secretion or binding in the plasma of ovarian and adrenal steroids have been discussed (see Denamur, 1971; Meites, 1966) . The present study was therefore undertaken to examine whether administration of cortisol or prolactin and pituitary graft under the kidney capsule can eliminate or reduce the depressive effect of estrogen on postpartum lactation. Experiment 3. Effect of direct implant of cortisol Daily systemic injections of EB into the mother inhibited lactation in a manner quite similar to that observed in Experiment 1 and 2. Gross examination of the mammary glands at autopsy showed a reduction in thickness and involutionary appearance in general in comparison with normally lactating glands, and these changes became more apparent with the length of the EB treatment. However, the localized presence of milk was recognized The present study demonstrated that the administration of cortisol could potently overcome a depression of the litter weight gain and a regression of the mammary glands caused by systemic injections of estradiol in postpartum lactating mice. This result suggests that adrenal corticoids are participating in the inhibitory process of established lactation by estrogen. It has been questioned whether the inhibitory action of estrogen takes place at the pituitary level by blocking the release of galactopoietic hormones, or it does occur in the mammary glands. Recent studies (Yokoi et al., 1969; Bruce and Ramirez, 1970) suggest that estrogen inhibition does not occur at pituitary level. Thus, the counteraction of cortisol in the present experiment may also not be elicited centrally, although corticoids may stimulate prolactin secretion by some means (Sar and Meites, 1968) . On the other hand, the result in Experiment 3 provided evidence that the counteraction of cortisol took place, at least in part, directly at the site of the mammary glands.
It appears likely that an antagonistic mechanism between corticoids and ovarian steroids, involving plasma corticoids binding globulin (CBG), which is similar to that has been postulated at the natural onset of lactogenesis (see Denamur, 1971; Meites, 1966) works also in the inhibitory mechanism of estrogen upon established lactation. However, such a systemic mechanism involving CBG could not account for a localized inhibitory effect of EB if it does exist. The This raises questions whether prolactin (not mouse origin) is ineffective or whether the amount of prolactin, either administered or secreted from grafted APs, is insufficient to counteract with EB, since only a single dose level of prolactin was employed and the number of grafted APs was 2 in this study. There are some indications that whereas both prolactin and adrenal corticoids are essential for milk secretion, adrenal corticoids but not prolactin would be a rate limiting factor to milk synthesis in mice and rats (see Cowie and Tindal, 1971) . Also in the present experiment, no galactopoietic effect was observed by AP graft. On the contary, a definite galactopoietic effect was observed in lactating rats by prolactin injection (Johnson and Meites, 1957) and by direct intracranial implant of EB which presumably stimulated prolactin secretion (Yokoi et al., 1969; Bruce and Ramirez, 1970) . The inconsistent responses in milk secretion to additional prolactin may depend upon the situations whether endogenous prolactin is already present sufficiently or not. However, recent studies have reported that systemic injections of large doses of estrogen (Chen and Meites, 1970) or implantation of EB in the hypothalamus (Nagasawa et al., 1969) stimulated but not inhibited the synthesis and release of pituitary prolactin. It has been already pointed out that not an absolute but a relative amount of prolactin to ovarian steroids is important for the induction of milk secretion Meites, 1953, 1954) . Therefore, the slight effectiveness of AP graft in the present study suggests that the decrease in a relative amount of prolactin to estrogen may be partially responsible for the inhibitory effect of EB upon established lactation. A similar mechanism was also postulated by recent studies that pituitary isograft could overcome or reduce the inhibitory effect of a large dose of estrogen on mammary growth in mice (Nagasawa and Yanai, 1971 ) and on mammary tumor incidence by carcinogen in rats (Nagasawa and Yanai, 1972) . The histological examination in Experiment 3 showed little retention of milk in alveoli of the mammary glands from the animals receiving EB. No appreciable sign of abnormality was detected in the maternal nursing behavior, and the uterine weight of young was not significantly influenced by EB treatments. These results indicate that disturbance of milk ejection, abnormal behavior and the transfer of estrogen into young via milk are little responsible for the depression of litter growth in this study. The food intake of the mother changed in a similar trend to the litter weight gain by each treatment and whether this change in food intake was the cause of or the result from that of the intensity of milk secretion could not be concluded. However, from the result in Experiment 3 that the implant of cortisol pellet over mammary glands evoked the localized maintenance of milk secretory activity under the influence of systemic EB, it is possible to say that the hormonal effect on milk secretion was not primarily mediated through the food intake under the present experimental conditions. It was reported in the lactating rat that the reduction of food intake of the mother could not account for the depression in litter growth by estrogen (Yokoyama et al., 1968 ; Yokoi et al., 1969) .
In our preliminary experiment, ovariectomy before EB administration did not significantly alter the inhibitory effect on litter growth, suggesting that the ovary may not participate in the inhibitory action of EB upon lactation. This is in contrast to the result in the rat (see Folley, 1952; Yokoyama et al., 1968) . Other hormones such as STH, thyroid hormones, insulin and parathormone are known to be necessary to elicit maximum production of milk, although they are not essential for milk secretion. Estrogen may influence on the secretion of these hormones. The incomplete recovery by cortisol from EB inhibition of lactation during the later period of treatment in the present study could be explained by the inadequate secretion of these hormones.
Summarizing, the present study clearly indicates that glucocorticoids may be intimately concerned in the lactation depressive mechanism of estrogen and act, at least in part, directly at the site of mammary tissues, although it is not the only hormone involved in this process. Essentially the same finding that cortisol could counteract with EB on established lactation was obtained also in rats by us (unpublished).
